Immediate Impact
58 standout
Citing Papers
Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial
2024 Standout
Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial
2023 Standout
Works of Alison Millson being referenced
Comparison of Two Quantitative Polymerase Chain Reaction Methods for Detecting HER2/neu Amplification
2003
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Alison Millson | 153 | 59 | 67 | 63 | 17 | 336 | |
| Debbie K. Song | 114 | 31 | 94 | 34 | 16 | 337 | |
| Mitesh Patel | 121 | 57 | 25 | 83 | 13 | 332 | |
| Clemens Reinshagen | 100 | 27 | 72 | 74 | 20 | 315 | |
| Pavlína Plevová | 144 | 111 | 25 | 112 | 33 | 386 | |
| Wanda Renaud | 154 | 59 | 44 | 60 | 17 | 407 | |
| L C Andersson | 151 | 11 | 32 | 63 | 17 | 391 | |
| M. Hedges | 148 | 56 | 42 | 39 | 22 | 369 | |
| Vijayalakshmi Shanmugam | 195 | 40 | 30 | 47 | 12 | 336 | |
| Camilla Holmlund | 297 | 28 | 59 | 96 | 16 | 397 | |
| Alison J. May | 143 | 65 | 59 | 40 | 14 | 377 |
All Works
Loading papers...